Comparison of prostate cancer detection rate at targeted biopsy of hub and spoke centers mpMRI: experience matters.


Journal

Minerva urology and nephrology
ISSN: 2724-6442
Titre abrégé: Minerva Urol Nephrol
Pays: Italy
ID NLM: 101777299

Informations de publication

Date de publication:
Feb 2023
Historique:
pubmed: 30 6 2022
medline: 22 2 2023
entrez: 29 6 2022
Statut: ppublish

Résumé

Latest changes in European guidelines on prostate cancer determined a widespread of multiparametric magnetic resonance imaging (mpMRI) even in less experienced centers due to an increased demand. This could decrease diagnostic accuracy of targeted biopsy (TB) since image interpretation can be challenging and requires adequate and supervised training. Therefore we aimed to evaluate the prostate cancer (PCa) detection rate on TB according to mpMRI center's volume and experience. We retrospectively analyzed data of 737 patients who underwent mpMRI-TB at our institution. Patients were stratified according to mpMRI center: Hub (high volume >100 exams/year with dedicated radiologists and supervised training) and Spoke center (low volume <100 exams/year without dedicated radiologists and/or supervised training). Detection rate of PCa at TB and possible predictors of clinically significant PCa (csPCa) at TB. Differences in detection rate were explored using Chi-square test. Predictors of csPCa were evaluated through uni and multivariable logistic regression. The adjustment for casemix included: age, PSA, mpMRI center, lesion's location, PSA density, PI-RADS score and index lesion's size. Four hundred forty-nine (60.9%) and 288 (39.1%) patients underwent mpMRI at a Hub or Spoke center, respectively. Hub group had higher detection rate for both any (60.3% vs. 48.1%) and csPCa (46.9% vs 38.7%; all P≤0.001). After stratifying for PI-RADS score, Hub group had higher detection rate for PI-RADS score 3 (csPCA 25.2% vs. 15.7%; p 0.04) and 4 (csPCa 65.7% vs. 45.7%; P=0.001). At multivariable analyses, receiving an mpMRI scan at a Spoke center was an independent predictor for csPCa on TB (OR 0.65; P=0.04). mpMRI performed in Hub centers provided a significantly higher PCa yield on TB. A dedicated team of experienced radiologist, a supervised training for mpMRI and a central revision of mpMRI performed in non-experienced centres are essential to avoid unnecessary and potentially harmful procedures.

Sections du résumé

BACKGROUND BACKGROUND
Latest changes in European guidelines on prostate cancer determined a widespread of multiparametric magnetic resonance imaging (mpMRI) even in less experienced centers due to an increased demand. This could decrease diagnostic accuracy of targeted biopsy (TB) since image interpretation can be challenging and requires adequate and supervised training. Therefore we aimed to evaluate the prostate cancer (PCa) detection rate on TB according to mpMRI center's volume and experience.
METHODS METHODS
We retrospectively analyzed data of 737 patients who underwent mpMRI-TB at our institution. Patients were stratified according to mpMRI center: Hub (high volume >100 exams/year with dedicated radiologists and supervised training) and Spoke center (low volume <100 exams/year without dedicated radiologists and/or supervised training). Detection rate of PCa at TB and possible predictors of clinically significant PCa (csPCa) at TB. Differences in detection rate were explored using Chi-square test. Predictors of csPCa were evaluated through uni and multivariable logistic regression. The adjustment for casemix included: age, PSA, mpMRI center, lesion's location, PSA density, PI-RADS score and index lesion's size.
RESULTS RESULTS
Four hundred forty-nine (60.9%) and 288 (39.1%) patients underwent mpMRI at a Hub or Spoke center, respectively. Hub group had higher detection rate for both any (60.3% vs. 48.1%) and csPCa (46.9% vs 38.7%; all P≤0.001). After stratifying for PI-RADS score, Hub group had higher detection rate for PI-RADS score 3 (csPCA 25.2% vs. 15.7%; p 0.04) and 4 (csPCa 65.7% vs. 45.7%; P=0.001). At multivariable analyses, receiving an mpMRI scan at a Spoke center was an independent predictor for csPCa on TB (OR 0.65; P=0.04).
CONCLUSIONS CONCLUSIONS
mpMRI performed in Hub centers provided a significantly higher PCa yield on TB. A dedicated team of experienced radiologist, a supervised training for mpMRI and a central revision of mpMRI performed in non-experienced centres are essential to avoid unnecessary and potentially harmful procedures.

Identifiants

pubmed: 35766364
pii: S2724-6051.22.04932-1
doi: 10.23736/S2724-6051.22.04932-1
doi:

Substances chimiques

Prostate-Specific Antigen EC 3.4.21.77

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

42-49

Auteurs

Matteo Droghetti (M)

Division of Urology, IRCCS University Hospital of Bologna, Bologna, Italy - droghet@gmail.com.

Lorenzo Bianchi (L)

Division of Urology, IRCCS University Hospital of Bologna, Bologna, Italy.

Caterina Gaudiano (C)

Department of Radiology, IRCCS University Hospital of Bologna, Bologna, Italy.

Beniamino Corcioni (B)

Department of Radiology, IRCCS University Hospital of Bologna, Bologna, Italy.

Arianna Rustici (A)

Department of Radiology, IRCCS University Hospital of Bologna, Bologna, Italy.

Pietro Piazza (P)

Division of Urology, IRCCS University Hospital of Bologna, Bologna, Italy.

Carlo Beretta (C)

Division of Urology, IRCCS University Hospital of Bologna, Bologna, Italy.

Eleonora Balestrazzi (E)

Division of Urology, IRCCS University Hospital of Bologna, Bologna, Italy.

Francesco Costa (F)

Division of Urology, IRCCS University Hospital of Bologna, Bologna, Italy.

Alberto Feruzzi (A)

Division of Urology, IRCCS University Hospital of Bologna, Bologna, Italy.

Marco Salvador (M)

Division of Urology, IRCCS University Hospital of Bologna, Bologna, Italy.

Francesca Giunchi (F)

Department of Pathology, IRCCS University Hospital of Bologna, Bologna, Italy.

Michelangelo Fiorentino (M)

Department of Pathology, IRCCS University Hospital of Bologna, Bologna, Italy.

Rita Golfieri (R)

Department of Radiology, IRCCS University Hospital of Bologna, Bologna, Italy.

Riccardo Schiavina (R)

Division of Urology, IRCCS University Hospital of Bologna, Bologna, Italy.

Eugenio Brunocilla (E)

Division of Urology, IRCCS University Hospital of Bologna, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH